Insider
| Ticker | Insider | Role | Type | Date | Shares | Price | Value | Notes | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Sale | 2026-09-10 | 11,480 | $24.97 | $286,656 | Disposed | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Sale | 2026-09-03 | 1,493 | $26.02 | $38,842 | Disposed | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Sale | 2026-09-02 | 6,510 | $27.27 | $177,495 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2026-08-19 | 70,000 | $28.95 | $2,026,850 | Disposed | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Sale | 2026-08-14 | 616 | $28.55 | $17,586 | Disposed | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 2026-08-14 | 715 | $28.55 | $20,413 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2026-08-12 | 977 | $28.49 | $27,835 | Disposed | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Option exercise | 2026-06-11 | 14,001 | $18.44 | $258,178 | Acquired | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Sale | 2026-06-11 | 14,001 | $20.71 | $289,919 | Disposed | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Option exercise | 2026-06-11 | 30,000 | $11.03 | $330,900 | Acquired | EDGAR |
| AORT | GREEN ANDREW M | SVP, Regulatory and Quality | Sale | 2026-06-11 | 30,000 | $20.69 | $620,820 | Disposed | EDGAR |
| AORT | SEMEDO ANTHONY B. | Director | J | 2026-06-02 | 6,325 | — | — | Disposed | EDGAR |
| AORT | Borgstrom Marna P | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | SEMEDO ANTHONY B. | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | BEVEVINO DANIEL J | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | Salveson Jon W | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | ACKERMAN THOMAS F | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | Bullock James | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | Hoff Elizabeth A | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | Burbank Jeffrey H | Director | Award | 2026-05-18 | 7,576 | — | — | Acquired | EDGAR |
| AORT | Borgstrom Marna P | Director | Award | 2026-05-14 | 7,850 | — | — | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2026-03-04 | 8,962 | $38.00 | $340,556 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2026-03-03 | 2,149 | $37.78 | $81,180 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2026-03-03 | 901 | $37.78 | $34,036 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2026-03-03 | 3,843 | $37.78 | $145,172 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2026-03-03 | 4,573 | $37.78 | $172,748 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2026-03-03 | 17,887 | $37.78 | $675,692 | Disposed | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 2026-03-03 | 6,316 | $37.78 | $238,591 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2026-03-02 | 2,784 | $38.02 | $105,861 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2026-03-02 | 2,183 | $38.02 | $83,008 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Award | 2026-03-02 | 116,948 | — | — | Acquired | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Award | 2026-03-02 | 40,874 | — | — | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Award | 2026-03-02 | 28,845 | — | — | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2026-03-02 | 14,911 | $38.02 | $566,989 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Award | 2026-03-02 | 21,838 | — | — | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2026-03-02 | 1,513 | $38.02 | $57,532 | Disposed | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 2026-03-02 | 5,178 | $38.02 | $196,893 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Award | 2026-03-02 | 7,475 | — | — | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Award | 2026-03-02 | 27,795 | — | — | Acquired | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2026-03-02 | 641 | $38.02 | $24,374 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Award | 2026-02-24 | 20,085 | — | — | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2026-02-24 | 1,259 | $35.69 | $44,937 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2026-02-24 | 830 | $35.69 | $29,625 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Award | 2026-02-24 | 5,658 | — | — | Acquired | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 2026-02-24 | 4,485 | $35.69 | $160,083 | Disposed | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Award | 2026-02-24 | 37,482 | — | — | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2026-02-24 | 2,075 | $35.69 | $74,063 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Award | 2026-02-24 | 20,438 | — | — | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Award | 2026-02-24 | 97,030 | — | — | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2026-02-24 | 13,936 | $35.69 | $497,418 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2026-02-24 | 1,668 | $35.69 | $59,536 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2026-02-23 | 3,079 | $37.59 | $115,733 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2026-02-23 | 3,773 | $37.59 | $141,820 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2026-02-23 | 2,423 | $37.59 | $91,076 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2026-02-23 | 20,962 | $37.59 | $787,920 | Disposed | EDGAR |
| AORT | Berry Lance A | EVP, COO, CFO & Treasurer | Sale | 2026-02-23 | 4,981 | $37.59 | $187,226 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2026-02-23 | 1,731 | $37.59 | $65,065 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-12-15 | 5,000 | $45.11 | $225,550 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-12-08 | 4,572 | $44.42 | $203,084 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-12-03 | 30,921 | $45.46 | $1,405,700 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-12-03 | 5,267 | $45.30 | $238,595 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-12-03 | 2,048 | $45.30 | $92,774 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Option exercise | 2025-12-03 | 30,921 | $29.62 | $915,880 | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Option exercise | 2025-12-02 | 30,921 | $29.62 | $915,880 | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-12-02 | 30,921 | $45.56 | $1,408,730 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Gift | 2025-12-01 | 750 | — | — | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-21 | 8,370 | $45.34 | $379,538 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise | 2025-11-21 | 20,301 | $18.44 | $374,350 | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-21 | 14,586 | $44.92 | $655,189 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-21 | 5,715 | $45.35 | $259,152 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-21 | 18,705 | $44.91 | $840,042 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise | 2025-11-21 | 27,075 | $11.03 | $298,637 | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-20 | 11,888 | $44.14 | $524,736 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise | 2025-11-20 | 1,355 | $11.03 | $14,946 | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-20 | 1,355 | $44.28 | $59,997 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-20 | 2,033 | $44.31 | $90,092 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise | 2025-11-20 | 2,033 | $18.44 | $37,489 | Acquired | EDGAR |
| AORT | Hoff Elizabeth A | Director | Sale | 2025-11-18 | 4,200 | $45.10 | $189,412 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Option exercise | 2025-11-17 | 6,394 | $29.62 | $189,390 | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-11-17 | 6,394 | $45.17 | $288,817 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Option exercise | 2025-11-17 | 6,394 | $29.62 | $189,390 | Acquired | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-11-17 | 6,000 | $45.73 | $274,380 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-11-17 | 6,394 | $45.17 | $288,817 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-11-14 | 6,393 | $44.67 | $285,575 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Option exercise | 2025-11-14 | 6,393 | $29.62 | $189,361 | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Option exercise | 2025-11-14 | 6,393 | $29.62 | $189,361 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-11-14 | 6,393 | $45.00 | $287,685 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-11-13 | 34,210 | $45.86 | $1,568,802 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-11-13 | 3,482 | $45.86 | $159,678 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-13 | 4,993 | $45.86 | $228,969 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-11-13 | 6,563 | $45.86 | $300,966 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-11-13 | 5,761 | $45.86 | $264,188 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Option exercise | 2025-11-11 | 10,000 | $11.03 | $110,300 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-11-11 | 10,000 | $46.18 | $461,800 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-11-10 | 1,789 | $44.62 | $79,823 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-11-10 | 2,566 | $44.62 | $114,492 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-11-10 | 3,373 | $44.62 | $150,500 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-11-10 | 17,580 | $44.62 | $784,402 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-11-10 | 2,960 | $44.62 | $132,072 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-08-27 | 18,200 | $44.02 | $801,219 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Option exercise | 2025-08-27 | 18,200 | $11.03 | $200,746 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Option exercise | 2025-08-25 | 10,000 | $11.03 | $110,300 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-08-25 | 10,000 | $44.37 | $443,700 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-08-15 | 12,500 | $42.32 | $528,988 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-08-12 | 6,381 | $43.02 | $274,498 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-08-12 | 10,802 | $43.67 | $471,756 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Option exercise | 2025-08-12 | 10,802 | $26.24 | $283,444 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-08-12 | 16,975 | $43.01 | $730,112 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Option exercise | 2025-08-12 | 16,975 | $26.24 | $445,424 | Acquired | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-08-08 | 7,992 | $38.49 | $307,612 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Option exercise | 2025-08-08 | 7,992 | $29.62 | $236,723 | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-06-17 | 1,236 | $29.50 | $36,462 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-06-17 | 13,764 | $29.50 | $406,038 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-06-13 | 1,826 | $28.43 | $51,909 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-06-13 | 14,306 | $28.42 | $406,601 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-06-13 | 1,253 | $28.47 | $35,669 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-06-13 | 8,747 | $28.46 | $248,953 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-05-27 | 8,748 | $29.00 | $253,692 | Disposed | EDGAR |
| AORT | SEMEDO ANTHONY B. | Director | Sale | 2025-05-23 | 2,600 | $28.47 | $74,027 | Disposed | EDGAR |
| AORT | Borgstrom Marna P | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | ACKERMAN THOMAS F | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | Salveson Jon W | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | SEMEDO ANTHONY B. | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | Hoff Elizabeth A | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | Burbank Jeffrey H | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | BEVEVINO DANIEL J | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | Bullock James | Director | Award | 2025-05-22 | 6,325 | — | — | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-05-21 | 9,926 | $29.00 | $287,854 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-05-09 | 4,811 | $29.13 | $140,145 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-05-09 | 5,737 | $29.13 | $167,120 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Option exercise | 2025-03-11 | 15,910 | $21.55 | $342,860 | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-03-11 | 15,100 | $23.61 | $356,549 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Option exercise | 2025-03-11 | 19,092 | $21.55 | $411,433 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-03-11 | 18,020 | $23.61 | $425,510 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-03-06 | 2,124 | $24.80 | $52,685 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-03-06 | 1,603 | $24.80 | $39,761 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Award | 2025-03-06 | 19,240 | — | — | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Option exercise | 2025-03-06 | 75,615 | $21.55 | $1,629,503 | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Award | 2025-03-06 | 115,701 | — | — | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-03-06 | 17,739 | $24.80 | $440,005 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-03-06 | 1,048 | $24.80 | $25,995 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Award | 2025-03-06 | 10,261 | — | — | Acquired | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-03-06 | 70,700 | $24.76 | $1,750,843 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Award | 2025-03-06 | 25,493 | — | — | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Award | 2025-03-06 | 25,654 | — | — | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-03-06 | 2,618 | $24.80 | $64,939 | Disposed | EDGAR |
| AORT | Berry Lance A | Executive VP, CFO | Sale | 2025-03-06 | 4,909 | $24.80 | $121,764 | Disposed | EDGAR |
| AORT | Berry Lance A | Executive VP, CFO | Award | 2025-03-06 | 48,100 | — | — | Acquired | EDGAR |
| AORT | SEMEDO ANTHONY B. | Director | Purchase | 2025-03-05 | 600 | $25.25 | $15,150 | Acquired | EDGAR |
| AORT | SEMEDO ANTHONY B. | Director | Purchase | 2025-03-05 | 1,500 | $25.33 | $37,990 | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-03-05 | 472 | $25.29 | $11,935 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Award | 2025-02-28 | 98,524 | — | — | Acquired | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Award | 2025-02-28 | 23,416 | — | — | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Award | 2025-02-28 | 18,398 | — | — | Acquired | EDGAR |
| AORT | Berry Lance A | Executive VP, CFO | Award | 2025-02-28 | 34,435 | — | — | Acquired | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Award | 2025-02-28 | 6,297 | — | — | Acquired | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Award | 2025-02-28 | 24,301 | — | — | Acquired | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-02-24 | 1,246 | $27.31 | $34,023 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-02-24 | 470 | $27.31 | $12,834 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-02-24 | 2,299 | $27.31 | $62,776 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-02-24 | 485 | $27.31 | $13,243 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-02-24 | 318 | $27.30 | $8,683 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-02-24 | 814 | $27.31 | $22,227 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2025-02-24 | 1,706 | $27.31 | $46,584 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-02-24 | 1,650 | $27.31 | $45,055 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-02-24 | 13,784 | $27.31 | $376,386 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-02-24 | 6,812 | $27.31 | $186,008 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-02-24 | 4,896 | $27.31 | $133,690 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-02-24 | 2,035 | $27.31 | $55,568 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-02-24 | 2,385 | $27.31 | $65,125 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-02-24 | 490 | $27.31 | $13,380 | Disposed | EDGAR |
| AORT | Stanton Marshall S. | SVP, Clinical & MD Affair | Sale | 2025-02-24 | 672 | $27.31 | $18,350 | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2025-02-24 | 810 | $27.31 | $22,118 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-02-24 | 2,846 | $27.31 | $77,713 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-02-24 | 591 | $27.31 | $16,138 | Disposed | EDGAR |
| AORT | Davis John E | Chief Commercial Officer | Sale | 2025-02-24 | 985 | $27.31 | $26,896 | Disposed | EDGAR |
| AORT | Berry Lance A | Executive VP, CFO | Sale | 2025-02-24 | 3,259 | $27.31 | $88,990 | Disposed | EDGAR |
| AORT | Mackin James P | President & CEO | Sale | 2025-02-24 | 16,664 | $27.31 | $455,027 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Gift | 2024-12-12 | 1,100 | — | — | Disposed | EDGAR |
| AORT | Holloway Jean F | SVP, General Counsel | Sale | 2024-12-11 | 4,035 | $30.25 | $122,059 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2024-12-06 | 4,425 | $29.05 | $128,552 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2024-12-06 | 4,329 | $29.66 | $128,398 | Disposed | EDGAR |
| AORT | GREEN ANDREW M | VP Regulatory | Sale | 2024-12-04 | 7,618 | $30.00 | $228,540 | Disposed | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Option exercise | 2024-10-01 | 12,430 | $21.55 | $267,866 | Acquired | EDGAR |
| AORT | Horton Amy | VP, Chief Accounting Officer | Sale | 2024-10-01 | 12,430 | $26.18 | $325,415 | Disposed | EDGAR |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status